Oncolytics Biotech Inc (ONCY)
1.04
-0.02
(-2.35%)
USD |
NASDAQ |
Apr 17, 16:00
1.04
0.00 (0.00%)
After-Hours: 19:49
Oncolytics Biotech Cash and Short Term Investments (Quarterly): 26.32M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 26.32M |
September 30, 2023 | 29.41M |
June 30, 2023 | 18.38M |
March 31, 2023 | 21.94M |
December 31, 2022 | 23.68M |
September 30, 2022 | 23.66M |
June 30, 2022 | 26.15M |
March 31, 2022 | 31.63M |
December 31, 2021 | 32.36M |
September 30, 2021 | 37.70M |
June 30, 2021 | 40.97M |
March 31, 2021 | 39.90M |
December 31, 2020 | 24.48M |
September 30, 2020 | 19.95M |
June 30, 2020 | 21.90M |
March 31, 2020 | 21.55M |
December 31, 2019 | 10.83M |
September 30, 2019 | 9.290M |
June 30, 2019 | 9.351M |
March 31, 2019 | 10.65M |
December 31, 2018 | 10.06M |
September 30, 2018 | 12.55M |
June 30, 2018 | 14.14M |
March 31, 2018 | 5.998M |
December 31, 2017 | 9.412M |
Date | Value |
---|---|
September 30, 2017 | 11.28M |
June 30, 2017 | 12.82M |
March 31, 2017 | 7.575M |
December 31, 2016 | 10.48M |
September 30, 2016 | 13.46M |
June 30, 2016 | 15.78M |
March 31, 2016 | 17.20M |
December 31, 2015 | 18.79M |
September 30, 2015 | 22.36M |
June 30, 2015 | 25.84M |
March 31, 2015 | 24.17M |
December 31, 2014 | 13.94M |
September 30, 2014 | 15.27M |
June 30, 2014 | 17.73M |
March 31, 2014 | 20.07M |
December 31, 2013 | 25.57M |
September 30, 2013 | 30.51M |
June 30, 2013 | 36.41M |
March 31, 2013 | 42.83M |
December 31, 2012 | 21.40M |
September 30, 2012 | 28.52M |
June 30, 2012 | 34.61M |
March 31, 2012 | 46.74M |
December 31, 2011 | 34.14M |
September 30, 2011 | 40.64M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
9.290M
Minimum
Sep 2019
40.97M
Maximum
Jun 2021
24.71M
Average
23.68M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
Acasti Pharma Inc | 25.11M |
Aurinia Pharmaceuticals Inc | 350.49M |
Edesa Biotech Inc | 4.268M |
Lexaria Bioscience Corp | 4.793M |
Xenon Pharmaceuticals Inc | 638.08M |